GoldState Music | $500,000,000 | (Apr 22, 2025)
CSignum | $8,021,670 | (Apr 22, 2025)
Terra Security | $7,500,000 | (Apr 22, 2025)
Certified by Founder
Lodge
ADARx Pharmaceuticals Inc.
start up
United States
- San Diego, CA
- 10/08/2023
- Series C
- $200,000,000
ADARx Pharmaceuticals, Inc., located in San Diego, is a clinical stage biotechnology company committed to turning cutting-edge science into life-saving therapeutics. ADARx has developed proprietary RNA targeting platforms and oligonucleotide delivery technologies for inhibition, degradation, and editing disease-causing mRNA. ADARx has a growing pipeline of RNA targeting therapeutics for treating diseases across a range of therapeutic areas including genetic, cardiometabolic, complement-mediated diseases and central nervous system diseases. We are well-financed by a syndicate of renowned VC firms.
ADARx currently has multiple active programs in development. Our lead candidate is at the clinical stage.
- Industry Biotechnology Research
- Website https://www.adarx.com/
- LinkedIn https://www.linkedin.com/company/adarx-pharmaceuticals-inc/
Brellium | $13,700,000 | (Apr 22, 2025)
Spur | $4,500,000 | (Apr 22, 2025)
Cosmic Robotics | $4,000,000 | (Apr 22, 2025)
Capsule | $12,000,000 | (Apr 22, 2025)
Kenzo Security | $45,000,000 | (Apr 22, 2025)
Electra.aero | $115,000,000 | (Apr 22, 2025)
ROH | $9,000,000 | (Apr 22, 2025)
Booked it | $3,316,375 | (Apr 18, 2025)
Exaforce Inc. | $75,000,000 | (Apr 18, 2025)